CUA Educational Content

CUA Speaker Tour: Theragnostics

Featuring: Michael Hofman (PET Modality Lead, Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging)

SESSION #1: PSMA Imaging: When should I use it and what are the pitfalls?

SESSION #2: Evidence-base for radiopharmaceuticals: Life-prolonging therapies for men with prostate cancer

SESSION #3: Next generation PSMA theragnostics: What is coming next?


This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of 1 hour of credit.

This program has received financial support from Abbvie and Bayer in the form of an educational grant.